SCHEMBL6362136

SCHEMBL6362136

COc1cccc(-c2nc(C3CCN(CCc4cccs4)CC3)n3ccccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
DRD2 P14416 2/20 0.40
DRD4 P21917 1/20 0.40
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
MAPK1 P28482 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2D6 P10635 3/20 0.39
TSHR P16473 3/20 0.39
CYP2C19 P33261 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CLK4 Q9HAZ1 2/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 3/20 0.39
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14291487 0.86 ADAM17 (0.43) OPRM1OPRD1OPRK1KCNK3KCNK9
SCHEMBL6039487 0.84 HRH1 (0.48) OPRM1OPRD1OPRK1DRD2DRD4
SCHEMBL14291924 0.81 BTK (0.44) KCNK3KCNK9TSHRALDH1A1SMN1; SMN2
SCHEMBL6039981 0.80 OPRM1 (0.48) OPRM1MCHR1HTR1ASLC6A4
SCHEMBL6039830 0.77 HTR1A (0.49) OPRM1DRD2DRD4ALDH1A1HTR1A
SCHEMBL6365086 0.77 HTR2C (0.47) KCNK3KCNK9MAPK1CYP1A2CYP3A4
SCHEMBL4726661 0.77 KCNK3 (0.47) KCNK3KCNK9TSHRALDH1A1SMN1; SMN2
SCHEMBL6039970 0.77 SIGMAR1 (0.47) OPRM1DRD2DRD4ALDH1A1HTR1A
SCHEMBL4778220 0.76 KCNK3 (0.46) KCNK3KCNK9MEN1KMT2AALDH1A1
SCHEMBL6039470 0.75 PRCP (0.47) DRD2DRD4CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050215555-A1 Imidazo[1,5-a]pyridine serotonin (5-HT) 5-HT2A receptor antagonists such as 1-phenyl-3-[1-(2-phenylethyl)piperidin-4-yl]imidazo[1,5-a]pyridine; psychological disorders, sleep disorders, addiction, cardiovascular disorders, epilepsy, glaucoma BLOVITRUM AB (SE) 2005-09-29 US claimed
US-20050215555-A1 Imidazo[1,5-a]pyridine serotonin (5-HT) 5-HT2A receptor antagonists such as 1-phenyl-3-[1-(2-phenylethyl)piperidin-4-yl]imidazo[1,5-a]pyridine; psychological disorders, sleep disorders, addiction, cardiovascular disorders, epilepsy, glaucoma BLOVITRUM AB (SE) 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215555-A1 Imidazo[1,5-a]pyridine serotonin (5-HT) 5-HT2A receptor antagonists such as 1-phenyl-3-[1-(2-phenylethyl)piperidin-4-yl]imidazo[1,5-a]pyridine; psychological disorders, sleep disorders, addiction, cardiovascular disorders, epilepsy, glaucoma HTR1A, HTR2A, HTR5A OPRM1 49/4885OPRD1 44/4885OPRK1 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.